Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants

被引:115
作者
Schwarz, D [1 ]
Kisselev, P
Cascorbi, I
Schunck, WH
Roots, I
机构
[1] Humboldt Univ, Med Ctr Charite, Inst Clin Pharmacol, D-10098 Berlin, Germany
[2] Byelarussian Acad Sci, Inst Bioorgan Chem, Minsk 220141, BELARUS
[3] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
关键词
D O I
10.1093/carcin/22.3.453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytochrome P450 1A1 (CYP1A1) plays a key role in the metabolism of carcinogens, such as benzo[a]pyrene (B[a]P) and metabolites to ultimate carcinogens. Three human allelic variants, namely wild-type (CYP1A1.1), CYP1A1.2 (I452V) and CYP1A1.4 (T461N), were coexpressed by coinfection of baculovirus-infected insect cells with human NADPH-P450 reductase, These recombinant enzymes (in microsomal membranes) were used to analyze whether CYP1A1 polymorphisms affect catalytic activities towards B[a]P and B[a]P-7,8-dihydrodiol. The complete spectrum of phase I metabolites, including the tetrahydrotetrols resulting from hydrolysis of the ultimate carcinogen, B[a]P-7,8-dihydrodiol-9,10-epoxide, was examined by HPLC. Wild-type enzyme showed the highest total metabolism of B[a]P, CYP1A1.2 was similar to 50%, and CYP1A1.4 similar to 70%, K-m values for all metabolites with CYP1A1.2 were generally significantly lower than with wild-type enzyme (e.g. B[a]P-7,8-diol formation: 13.8 muM for wild-type, 3.5 muM for CYP1A1.2 and 7.7 muM for CYP1A1.4), Addition of epoxide hydrolase markedly increases the relative diol-to-phenol activities by all three variants. However, CYP1A1.4 exhibits the greatest efficiency to produce diol species. Each variant produced the diol epoxides from B[a]P-7,8-dihydrodiol. CYP1A1,1 exhibited with 10.4 pmol/min/pmol CYP1A1 the greatest total rate for 7,8-diol metabolites follow-ed by CYPIA1.2 (7.2 pmol/min/pmol CYP1A1) and CYP1A1.4 (5.5 pmol/min/pmol CYP1A1), All enzyme variants produced about three times more diol epoxide 2-derived metabolites than diol epoxide 1-derived ones, whereby both rare allelic variants exhibited statistically significantly increased formation of diol epoxide 2, This study showed that the three CYP1A1 variants had different enzyme kinetics properties to produce both the diol metabolites from B[a]P and the ultimate mutagenic species diol epoxide 2 from B[a]P-7,8-dihydrodiol, which must be considered in the evaluation of individual susceptibility to cancer.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 45 条
[21]   HUMAN DIOXIN-INDUCIBLE CYTOCHROME-P1-450 - COMPLEMENTARY-DNA AND AMINO-ACID SEQUENCE [J].
JAISWAL, AK ;
GONZALEZ, FJ ;
NEBERT, DW .
SCIENCE, 1985, 228 (4695) :80-83
[22]  
Jourenkova-Mironova N, 2000, CANCER RES, V60, P534
[23]   THE CYP1A1 GENE AND CANCER SUSCEPTIBILITY [J].
KAWAJIRI, K ;
NAKACHI, K ;
IMAI, K ;
WATANABE, J ;
HAYASHI, S .
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1993, 14 (01) :77-87
[24]   Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1 [J].
Kim, JH ;
Stansbury, KH ;
Walker, NJ ;
Trush, MA ;
Strickland, PT ;
Sutter, TR .
CARCINOGENESIS, 1998, 19 (10) :1847-1853
[25]   The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population [J].
Kiyohara, C ;
Nakanishi, Y ;
Inutsuka, S ;
Takayama, K ;
Hara, N ;
Motohiro, A ;
Tanaka, K ;
Kono, S ;
Hirohata, T .
PHARMACOGENETICS, 1998, 8 (04) :315-323
[26]  
Lloyd DR, 2000, CANCER RES, V60, P517
[27]   CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping [J].
Mrozikiewicz, PM ;
Cascorbi, I ;
Brockmoller, J ;
Roots, I .
PHARMACOGENETICS, 1997, 7 (04) :303-307
[28]  
NAKACHI K, 1991, CANCER RES, V51, P5177
[29]   Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues [J].
Nebert, DW ;
Ingelman-Sundberg, M ;
Daly, AK .
DRUG METABOLISM REVIEWS, 1999, 31 (02) :467-487
[30]  
OMURA T, 1964, J BIOL CHEM, V239, P2370